Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14% |
| 2 | Energy | 11.19% |
| 3 | Financials | 8.75% |
| 4 | Consumer Discretionary | 8.58% |
| 5 | Industrials | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRGA
1301
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $5.81M | 0.01% |
29,996
+7,968
| +36% | +$1.48M |
|
|
VRTV
1302
DELISTED
VERITIV CORPORATION
VRTV
| $5.8M | 0.01% |
159,224
-5,000
| -3% | -$203K |
|
1303
Diageo
DEO
$49.5B
| $5.8M | 0.01% |
50,000
+13,171
| +36% | +$1.5M |
|
1304
Southwest Gas
SWX
$6.54B
| $5.79M | 0.01% |
108,779
+6,761
| +7% | +$371K |
|
|
CELG
1305
PUT
DELISTED
Celgene Corp
CELG
| $5.79M | 0.01% |
50,000
-800
| -2% | -$91.5K |
|
1306
Arista Networks
ANET
$215B
| $5.78M | 0.01% |
1,131,456
+859,328
| +316% | +$3.84M |
|
|
PPS
1307
DELISTED
Post Properties
PPS
| $5.78M | 0.01% |
106,235
-73,001
| -41% | -$4.11M |
|
|
PDLI
1308
DELISTED
PDL BioPharma, Inc.
PDLI
| $5.76M | 0.01% |
896,615
-377,831
| -30% | -$2.53M |
|
|
TVTY
1309
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $5.75M | 0.01% |
480,095
-973,764
| -67% | -$16.2M |
|
1310
CALL
Humana
HUM
$44B
| $5.74M | 0.01% |
+30,000
| New | +$5.57M |
|
1311
Tonix Pharmaceuticals
TNXP
$161M
| – | – |
0
| – | – |
|
1312
NVR
NVR
$16.8B
| $5.73M | 0.01% |
4,275
-10,042
| -70% | -$13.5M |
|
|
FTRPR
1313
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
| $5.73M | 0.01% |
+57,350
| New | +$5.75M |
|
|
SPLS
1314
DELISTED
Staples Inc
SPLS
| $5.73M | 0.01% |
374,053
-2,312,927
| -86% | -$37.7M |
|
1315
Wolverine World Wide
WWW
$1.64B
| $5.71M | 0.01% |
+200,433
| New | +$6.14M |
|
1316
CALL
Walt Disney
DIS
$167B
| $5.71M | 0.01% |
+50,000
| New | +$5.49M |
|
|
INFN
1317
DELISTED
Infinera Corporation Common Stock
INFN
| $5.7M | 0.01% |
271,771
+77,447
| +40% | +$1.57M |
|
1318
Glaukos
GKOS
$9.94B
| $5.68M | 0.01% |
+196,176
| New | +$5.7M |
|
|
QLTY
1319
DELISTED
QUALITY DISTR INC FLA
QLTY
| $5.68M | 0.01% |
367,585
-136
| -0% | -$1.84K |
|
1320
Morgan Stanley
MS
$330B
| $5.67M | 0.01% |
146,258
+99,189
| +211% | +$3.77M |
|
|
ENLC
1321
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $5.67M | 0.01% |
182,427
-312,752
| -63% | -$10.5M |
|
1322
Chord Energy
CHRD
$7.78B
| $5.65M | 0.01% |
356,704
-63,583
| -15% | -$1.07M |
|
1323
Rigel Pharmaceuticals
RIGL
$704M
| $5.64M | 0.01% |
175,665
-6,214
| -3% | -$237K |
|
1324
CALL
Golar LNG
GLNG
$4.91B
| $5.62M | 0.01% |
120,000
+50,000
| +71% | +$2.17M |
|
1325
CALL
Ally Financial
ALLY
$13.2B
| $5.61M | 0.01% |
250,000
+150,000
| +150% | +$3.31M |
|
Similar funds
Millennium Management's Q2 2015 Portfolio in Review
As of Q2 2015, Millennium Management held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Millennium Management's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Energy and Financials.
- Millennium Management's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Millennium Management added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Millennium Management's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Millennium Management fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Millennium Management's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Millennium Management opened 780 new positions and closed 1,034 in Q2 2015.
- Millennium Management's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.